• Title of article

    Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells

  • Author/Authors

    Yang، نويسنده , , Yili and Ludwig، نويسنده , , Robert L. and Jensen، نويسنده , , Jane P. and Pierre، نويسنده , , Shervon A. and Medaglia، نويسنده , , Maxine V. and Davydov، نويسنده , , Ilia V. and Safiran، نويسنده , , Yassamin J. and Oberoi، نويسنده , , Pankaj and Kenten، نويسنده , , John H. and Phillips، نويسنده , , Andrew C. and Weissman، نويسنده , , Allan M. and Vousden، نويسنده , , Karen H.، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2005
  • Pages
    13
  • From page
    547
  • To page
    559
  • Abstract
    Summary 3 tumor suppressor protein is regulated by its interaction with HDM2, which serves as a ubiquitin ligase (E3) to target p53 for degradation. We have identified a family of small molecules (HLI98) that inhibits HDM2’s E3 activity. These compounds show some specificity for HDM2 in vitro, although at higher concentrations effects on unrelated RING and HECT domain E3s are detectable, which could be due, at least in part, to effects on E2-ubiquitin thiol-ester levels. In cells, the compounds allow the stabilization of p53 and HDM2 and activation of p53-dependent transcription and apoptosis, although other p53-independent toxicity was also observed.
  • Journal title
    Cancer Cell
  • Serial Year
    2005
  • Journal title
    Cancer Cell
  • Record number

    1335647